$LGN

Legence Reports Q2 2026: Record $1.26B Revenue, Adjusted EBITDA $154.6M, Backlog $5.67B

Legence Corp. reported Q2 2026 revenue of $1.262B and non-GAAP Adjusted EBITDA of $154.6M, citing 110.7% YoY growth and backlog and awarded contracts of $5.67B. The company raised full-year 2026 revenue and EBITDA guidance based on backlog and demand. Q2 net loss was $27.8M, with cash of $292M and total debt of $1.03B.

Original reporting
Published Aug 13, 2026, 11:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Legence Reports Q2 2026: Record $1.26B Revenue, Adjusted EBITDA $154.6M, Backlog $5.67B — source image
Decision brief

The 30-second read

$LGNBullishMed
01

Why it matters

The combination of record revenue, strong backlog growth to $5.67B, a 1.2x book-to-bill, and raised full-year revenue and Adjusted EBITDA guidance is likely to shift expectations for forward cash earnings power.

02

Market read

This is a primary earnings-and-guidance update with quantified backlog and book-to-bill, which can drive near-term repricing of FY 2026 estimates.

03

What to watch

Backlog size is supportive, but traders will likely focus on backlog quality, timing of project starts, and whether acquisition-related growth (Bowers) sustains without margin dilution.

Relevance 8/10Novelty 7/10Timing: pre-market today (Aug. 13, 2026) after Q2 2026 results and guidance raise

Background

Legence is reporting Q2 2026 results and updating FY 2026 guidance, emphasizing backlog and contract awards as the visibility driver.

Company-level read

Ticker impact

$LGNBullishMedium confidence
Context

Legence reported Q2 2026 record revenue of $1.262B, Adjusted EBITDA of $154.6M, and raised full-year guidance on $5.67B backlog.

Expected impact

Near-term bias to the upside as traders reprice FY 2026 revenue and Adjusted EBITDA expectations; follow-through depends on backlog conversion and margin trajectory.

Evidence & confidence

The article is a primary disclosure (8-K) with multiple quantified results plus explicit full-year guidance increases, which typically drives repricing versus prior expectations.

Market effects

Strength in data-center and technology end-market demand may reinforce sentiment toward engineering, installation, and maintenance contractors with similar backlog-driven models.

State and local government plus data-center demand mix suggests continued capex and infrastructure spending support in the US.

Limited direct global read-through; primarily a US contractor demand and backlog story.

Counterpoint

Margin is only 17.4% gross and net loss persists, so the market may question how much of the backlog growth converts into durable profitability.

Key entities

  • Legence Corp.

    Reported Q2 2026 record revenue and Adjusted EBITDA, with backlog of $5.67B and raised full-year guidance.

Related articles

MedAI 8/10

Legence Q2 2026 slides: record revenue, backlog despite margin pressure

Legence Corp. reported Q2 2026 results on Aug. 13, citing record revenue and backlog growth tied to data center and mission-critical building systems demand. Revenue rose to $1.262B (+111% YoY) and backlog to $5.67B (+105%). Adjusted EPS was -$0.37 vs +$0.21 expected. Shares fell over 7% to $63.68; full-year guidance was raised to $4.7B-$4.8B revenue.

$LGNMedAI 8/10

Legence revenue rises 110.7% to $1.26 billion

Legence (NASDAQ:LGN) reported Q2 2026 revenue of $1.26 billion, up 110.7% year over year, and Adjusted EBITDA of $154.6 million. The company posted a net loss of $27.8 million and ended with $292 million cash and $1.03 billion debt. It raised FY2026 revenue guidance to $4.7–$4.8 billion and Adjusted EBITDA to $565–$585 million.

$LGNMed

Legence Q3 Results: Sales Guidance $1.225B

Legence (NASDAQ: LGN) guided Q3 sales to $1.225B to $1.275B, above the $1.080B analyst consensus. The low end is about $145M higher, implying roughly 13% above street expectations. No other financial metrics were provided in the source.

Med

Legence Corp. Revises Earnings Guidance for Full Year 2026

Legence Corp. revised its full-year 2026 earnings guidance, raising expected total revenues to $4.7 billion to $4.8 billion from a prior range of $4.1 billion to $4.3 billion. The company provides engineering, installation and maintenance services for mission-critical building systems, operating in Engineering & Consulting and Installation & Maintenance segments.